Healthcare fraud costs states and the federal government billions of dollars each year, much of it involving prescription drugs. Common types of prescription fraud include, but are not limited to, billing 3rd parties, especially government entities, for (a) prescriptions never picked up by patients but whose insurance claims are not reversed, (b) prescriptions billed and dispensed to a previous patient, subsequently returned to the pharmacy, and re-dispensed and re-billed to a second patient, (c) expensive compounded pain creams for which there are no legitimate uses, (d) diabetic testing supplies obtained from non-approved suppliers, (e) prescriptions for which there is no evidence the pharmacy had sufficient inventory in stock to fill, (f) prescriptions in which the product dispensed was different than the product billed for, (g) “imaginary” prescriptions for real patients, and (h) prescriptions that were not medically necessary such as unauthorized refills, controlled substance prescriptions where “corresponding responsibility” was not met, and items for which there are no legitimate medical use.
Jack has extensive experience working with the United States Department of Health and Human Services, the United States Department of Justice, commercial prescription drug benefit providers, and attorneys representing Qui tam relators (“whistleblowers”) in false claims and fraud investigations involving 3rd party pharmacy benefits. He also has extensive experience working with attorneys defending pharmacy providers accused of the same. Services include, but are not limited to, oversight and compliance audits of prescription drug benefit programs and litigation assistance and expert testimony in actions both in support of, and against, pharmacy providers.
Jack Raber is an active member of the Academy of Managed Care Pharmacy (AMCP) and the American Society for Pharmacy Law.
